Markets & Regulations

Lilly invests heavily in UK

Lilly invests heavily in UK

US pharmaceutical major Eli Lilly has earmarked a hefty £220
million (€304 million) investment over the next four years in its
UK facilities, representing the largest investment by the firm in
any European country.

Follow us

Products

View more

Webinars